Rogaratinib (BAY1163877) Human Mass Balance Study
NCT03484585
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Clinical Trial, Phase I
Pharmacokinetics
Interventions
DRUG:
Rogaratinib (BAY1163877)
Sponsor
Bayer